News
Company News
CURE/China activity in Shenzhen
On August 11th, one of HLK's scientific advisors, Dr. Yijun Cheng, made his first trip to Shenzhen. Dr. Cheng is a medical oncologist/hematologist engaged in private practice in Williamsville, New York. Yijun presented on: PD-1 and CAR-T, Cancer Immunotherapy, Perspective from a Clinician, at the High Tech Park in Shenzhen and it was well received by more than 80 people from 32 organizations. Most audience members were management members of the companies, some investors, or journalists. It was a joint effort from the organizers; the Bio Incubator, CURE/China, Nanjing University Pharmaceutical Institute, and Shenzhen Life Science and Biotechnology Association.    Dr. Cheng earned his medical degree at the Second Military Medical University in Shanghai, China. In addition, he received a PhD in cancer biology at the University of Texas M.D. Anderson Cancer Center. He completed internal medicine and medical oncology/hematology specialty training in University at Buffalo (UB)-affiliated hospitals and the Roswell Park Cancer Institute.  Licensed to practice in the State of New York and State of Pennsylvania, Dr. Cheng is board certified by American Board of Internal Medicine, American Board of Medical Oncology and American Board of Hematology. He is a member of the American College of Physicians, American Society of Clinical Oncology and American Society of Hematology. He has worked with several Pharmaceutical and Biotechnology companies as clinical consultant over the years.
1/1 Page Total1 Ttem   Prev 1 Next   Jump To page
Tel: +86-755-86007001   Email: info@hlkpharma.com